Based on Science Daily, treating patients with the locally advanced inoperable breast cancer is a difficult task. Most patients treated with this disease suffer relapse and despite the finest multimodal treatment, they don't survive. There's a medical need for examining the potential and current treatments and researchers of EORTC have published an article based on this topic.
Dr. Konstantinos Tryfonidis of EORTC said that locally advanced breast cancer is the term, which includes different breast tumors, which range from big operable cancers with an extensive nodal involvement to the inflammatory breast carcinomas. Indeed, several huge operable breast tumors might fit in such categories, yet they have decided to limit their discussion to the inoperable concerns. Therefore, they are addressing inoperable cases because of extensive skin involvement, very bulky or fixed axillary nodal disease or internal mammary involvement of nodal or the tumors with the inflammatory elements.
Dr. Fatima Cardoso of Champalimaud Clinical Centre based in Lisbon, Portugal as well as corresponding author of the review pointed out that the prognosis for the patients with such tumors are often unfavorable, yet the advances in therapy provide some hope. Even if not very often in the developed countries, the locally advanced inoperable breast cancer is a challenging clinical issue in developing countries, especially those without education or screening or awareness programs.
13wHam reported that it is a disease, which can affect any woman, yet for some, the odds to survive from breast cancer may not be in their favor. Breast Cancer Action stated that the disease tends to impact several women of various races similarly. However, research shows while Caucasian women have higher incidence rate of the medical condition, women of color, especially African-Americans tend to acquire an aggressive type of it and are more likely to die from breast cancer.
